Feasibility of 18F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 5105-5110

  Yamada, Isamu ^a,b   Ajiki, Tetsuo ^a   Ueno, Kimihiko ^a   Sawa, Hidehiro ^a   Otsubo, Izuru ^a   Yoshida, Yuko ^a   Shinzeki, Makoto ^a   Toyama, Hirochika ^a   Matsumoto, Ippei ^a   Fukumoto, Takumi ^a   Nakao, Atsunori ^b   Kotani, Joji ^b   Ku, Yonson ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

18F labeled fluorodeoxyglucose positron emission tomography; Bile duct cancer; False positive; Inflammation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER DIAGNOSIS; CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; EXTRAHEPATIC BILE DUCT CANCER; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GALLBLADDER CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CANCER; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84872648246     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Morise Z, Sugioka A, Tokoro T, Tanahashi Y, Okabe Y, Kagawa T and Takeura C: Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2: 58-64, 2010.
2. 18F-fluorodeoxyglucose PET: Prospective comparison with PET+CT, MDCT and histopathology. Eur Radiol 18: 2841-2847, 2008.
3. 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103: 1145-1151, 2008.
4. Rodriguez-Fernandez A, Gomez-Rio M, Llamas-Elvira JM, Ortega-Lozano S, Ferron-Orihuela J A, Ramia-Angel JM, Mansilla-Rosello A, Martinez-del-Valle MD and Ramos-Font C: Positron-emission tomography with fluorine-18-fluoro-2-deoxy- D-glucose for gallbladder cancer diagnosis. Am J Surg 188: 171-175, 2004.
5. Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D and Berr F: Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33: 1029-1035, 2001.
6. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS and Delbeke D: Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8: 90-97, 2004.
7. Nishiyama Y, Yamamoto Y, Kimura N, Miki A, Sasakawa Y, Wakabayashi H and Ohkawa M: Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nucl Med Commun 28: 914-919, 2007.
8. 18fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery 143: 769-777, 2008.
9. Kitajima K, Murakami K, Kanegae K, Tamaki N, Kaneta T, Fukuda H, Nakajima K, Fujii H, Tateishi U, Kubota K, Suga T and Nakamoto Y: Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study. Ann Nucl Med 23: 709-715, 2009.
10. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours. 6th ed. Hoboken, New Jersey: John Wiley & Sons; 2002.
11. Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL and Neifakh SA: Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 61: 27-34, 1978.
12. Reske SN, Grillenberger KG, Glatting G, Port M, Hildebrandt M, Gansauge F and Beger HG: Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med 38: 1344-1348, 1997.
13. Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, Takeda Y, Tanemura M, Kim T, Shimosegawa E, Hatazawa J, Doki Y and Mori M: Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol 103: 223-229, 2011.
14. 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 33: 148-155, 2006.
15. Chen CH, Muzic RF Jr., Nelson AD and Adler LP: Simultaneous recovery of size and radioactivity concentration of small spheroids with PET data. J Nucl Med 40: 118-130, 1999.